Review confidentially
Analysis under NDA in a protected environment. No provider sees another’s raw prices; no names shared with manufacturers at the outset.
For providers & owners Better terms.
Better terms.
No operational change.
Your facility should care for patients — not run negotiations. AIONA compares real net-net terms across a circle of independent providers, identifies the best value per product and negotiates it with manufacturers, backed by aggregated demand. It only becomes binding once the full advantage is on the table.
78 providers in the partner & prospect circle
€635 m aggregated annual revenue within the circle
35,000 + addressable articles & products
18,467 reviewed & analysed article positions
Partner and prospect circle with varying degrees of commitment. Revenue shown is provider revenue, not procurement volume. As of July 2026.
Three principles
Review confidentially. Implement only on proven advantage.
You contribute data and restrictions. AIONA delivers the benchmark, the manufacturer offer and the implementation plan — only then do you decide.
Implement only on proven advantage
Price, quality, service and the supply concept are fully on the table — only then do you decide.
Keep your existing supply
Manufacturers or authorised distributors continue to supply, invoice and serve you directly.
Your benefit
Four advantages for your facility.
Better net-net terms
The best value in the circle is identified at article level — and negotiated for all, backed by aggregated demand.
No operational change
Supply routes, systems and contacts remain. Analysis phase without upfront fee or commitment.
Clinical authority stays
AIONA presents — your clinicians and your procurement decide. Supported, documented, reversible.
Protected data room
NDA, strict access control, no disclosure of raw prices — discretion by design.
The next step
Review together. Decide only on advantage.
Entry: one NDA, two to three pilot categories — with no purchase obligation during the analysis phase.
NDA & data extract
Selected twelve-month data and restrictions — confidentially, without upfront commitment.
Benchmark & offer
The economic lever at article level, plus the concrete manufacturer offer with an implementation plan.
Release & pilot
Only now do you decide. Supply remains direct — with continuous reporting.
Founding partners
Save in your own procurement. Participate in the growth.
The founding-partner circle is deliberately limited: priority in shaping the programme, preferred access to pilot categories — and optional economic participation at provider level. Structure and terms are discussed in person only.
Subject to legal, tax, competition-law and compliance review; no transaction-based remuneration to individuals.
View the founding partner programme Your supply authority remains untouched: manufacturers or authorised
distributors continue to supply, invoice and serve you directly. Product
conversions only proceed after clinical approval by your clinicians — supported,
documented and reversible.
For providers
One NDA. Two to three categories. One clear proof.
We show you, on your own data, where the economic lever sits — at article level, confidentially and without upfront commitment.
Arrange a conversation